JPWO2013180019A1 - Liquid oral composition - Google Patents
Liquid oral composition Download PDFInfo
- Publication number
- JPWO2013180019A1 JPWO2013180019A1 JP2014518421A JP2014518421A JPWO2013180019A1 JP WO2013180019 A1 JPWO2013180019 A1 JP WO2013180019A1 JP 2014518421 A JP2014518421 A JP 2014518421A JP 2014518421 A JP2014518421 A JP 2014518421A JP WO2013180019 A1 JPWO2013180019 A1 JP WO2013180019A1
- Authority
- JP
- Japan
- Prior art keywords
- component
- liquid oral
- composition
- mass
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 64
- 239000007788 liquid Substances 0.000 title claims abstract description 40
- -1 acyl sarcosine salt Chemical class 0.000 claims abstract description 43
- 210000000214 mouth Anatomy 0.000 claims abstract description 29
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 claims abstract description 13
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 12
- 239000002324 mouth wash Substances 0.000 claims abstract description 11
- 229940051866 mouthwash Drugs 0.000 claims abstract description 11
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 10
- 239000010452 phosphate Substances 0.000 claims abstract description 10
- 238000009472 formulation Methods 0.000 claims abstract description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 22
- 239000011734 sodium Substances 0.000 claims description 22
- 229910052708 sodium Inorganic materials 0.000 claims description 22
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 17
- 239000000194 fatty acid Substances 0.000 claims description 17
- 229930195729 fatty acid Natural products 0.000 claims description 17
- 239000003205 fragrance Substances 0.000 claims description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 11
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 10
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 10
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000003945 anionic surfactant Substances 0.000 claims description 9
- 235000011187 glycerol Nutrition 0.000 claims description 8
- 235000019832 sodium triphosphate Nutrition 0.000 claims description 7
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 6
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 claims description 6
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 6
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 6
- 108700004121 sarkosyl Proteins 0.000 claims description 6
- LFJJOPDNPVFCNZ-UHFFFAOYSA-N 2-[hexadecanoyl(methyl)amino]acetic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N(C)CC(O)=O LFJJOPDNPVFCNZ-UHFFFAOYSA-N 0.000 claims description 5
- NGOZDSMNMIRDFP-UHFFFAOYSA-N 2-[methyl(tetradecanoyl)amino]acetic acid Chemical compound CCCCCCCCCCCCCC(=O)N(C)CC(O)=O NGOZDSMNMIRDFP-UHFFFAOYSA-N 0.000 claims description 5
- 239000002280 amphoteric surfactant Substances 0.000 claims description 5
- 239000003093 cationic surfactant Substances 0.000 claims description 5
- 108700009886 palmitoyl sarcosine Proteins 0.000 claims description 5
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 claims description 5
- 229940048086 sodium pyrophosphate Drugs 0.000 claims description 5
- 239000004094 surface-active agent Substances 0.000 claims description 5
- 235000019818 tetrasodium diphosphate Nutrition 0.000 claims description 5
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims description 5
- 239000000551 dentifrice Substances 0.000 claims description 4
- 239000000080 wetting agent Substances 0.000 claims description 4
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000019634 flavors Nutrition 0.000 claims description 2
- 230000007794 irritation Effects 0.000 abstract description 24
- 235000019606 astringent taste Nutrition 0.000 abstract description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 13
- 238000011156 evaluation Methods 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 10
- 235000021317 phosphate Nutrition 0.000 description 9
- 239000004359 castor oil Substances 0.000 description 8
- 235000019438 castor oil Nutrition 0.000 description 8
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 8
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 8
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 6
- 235000019799 monosodium phosphate Nutrition 0.000 description 6
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000811 xylitol Substances 0.000 description 5
- 235000010447 xylitol Nutrition 0.000 description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 5
- 229960002675 xylitol Drugs 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 239000003002 pH adjusting agent Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 4
- 235000010234 sodium benzoate Nutrition 0.000 description 4
- 239000004299 sodium benzoate Substances 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 150000005846 sugar alcohols Chemical class 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 240000002657 Thymus vulgaris Species 0.000 description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- 229960002684 aminocaproic acid Drugs 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 235000021539 instant coffee Nutrition 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 2
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000137 polyphosphoric acid Polymers 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000001585 thymus vulgaris Substances 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- GIXFALHDORQSOQ-UHFFFAOYSA-N 2,4,6,8-tetrahydroxy-1,3,5,7,2$l^{5},4$l^{5},6$l^{5},8$l^{5}-tetraoxatetraphosphocane 2,4,6,8-tetraoxide Chemical compound OP1(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)O1 GIXFALHDORQSOQ-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 239000005749 Copper compound Substances 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- JVOGSHDZLOJKKR-MXFMKSRJSA-I [Na+].[Na+].[Na+].[Mg++].CCc1c(C)c2cc3[n-]c(c(C)c3C=C)c(C)c3nc(C[C@H]3CCC([O-])=O)c(CC([O-])=O)c3[n-]c(cc1n2)c(C)c3C([O-])=O Chemical compound [Na+].[Na+].[Na+].[Mg++].CCc1c(C)c2cc3[n-]c(c(C)c3C=C)c(C)c3nc(C[C@H]3CCC([O-])=O)c(CC([O-])=O)c3[n-]c(cc1n2)c(C)c3C([O-])=O JVOGSHDZLOJKKR-MXFMKSRJSA-I 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- FRHBOQMZUOWXQL-UHFFFAOYSA-K azane;2-hydroxypropane-1,2,3-tricarboxylate;iron(3+) Chemical compound N.[Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FRHBOQMZUOWXQL-UHFFFAOYSA-K 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- 229940108925 copper gluconate Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- AZSFNUJOCKMOGB-UHFFFAOYSA-N cyclotriphosphoric acid Chemical compound OP1(=O)OP(O)(=O)OP(O)(=O)O1 AZSFNUJOCKMOGB-UHFFFAOYSA-N 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000004313 iron ammonium citrate Substances 0.000 description 1
- 235000000011 iron ammonium citrate Nutrition 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940070802 palmitoyl glutamate Drugs 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 229940048084 pyrophosphate Drugs 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 229950005425 sodium myristyl sulfate Drugs 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
歯牙のステイン付着抑制効果が向上し、また、収れん感や刺激が抑えられ、適用後の口腔内がべたつくこともなく、特に洗口時の使用感が良好な、澄明性の高い製剤外観を有する液体口腔用組成物を提供する。(A)縮合リン酸塩、(B)ヒドロキシアルキルセルロース、(C)アシルサルコシン塩及び(D)ノニオン性界面活性剤を含有してなることを特徴とする液体口腔用組成物。Improves stain adhesion on teeth, reduces astringency and irritation, prevents stickiness in the oral cavity after application, and has a highly clear formulation appearance that is particularly good when used in mouthwash. A liquid oral composition is provided. A liquid oral composition comprising (A) a condensed phosphate, (B) a hydroxyalkyl cellulose, (C) an acyl sarcosine salt, and (D) a nonionic surfactant.
Description
本発明は、歯牙のステイン付着を抑制する効果が向上し、また、収れん感や刺激が抑えられ、特に洗口後の使用感が良好な、澄明性の高い製剤外観を有する液体口腔用組成物に関する。 The present invention provides a liquid oral composition having a highly clear formulation appearance, which has an improved effect of suppressing the adhesion of stains to teeth, has reduced convergence and irritation, and particularly has a good feeling after use. About.
口腔用組成物において、縮合リン酸が歯牙のステイン付着抑制効果を奏することは知られている(特許文献1;特開2000−281548号公報)が、特に液体口腔用組成物においてステイン付着抑制効果の更なる向上が求められていた。 In oral compositions, it is known that condensed phosphoric acid has an inhibitory effect on tooth stain adhesion (Patent Document 1; JP 2000-281548 A), but particularly in a liquid oral composition. There was a need for further improvement.
また、縮合リン酸は、口腔用組成物に配合すると収れん感や刺激が生じ使用感に不具合をもたらし(特許文献2;特開平10−167940号公報、特許文献3;特開2009−155286号公報)、特に洗口後に収れん感や刺激が強く発現するという問題があった。 In addition, when condensed phosphoric acid is blended into an oral composition, it causes a feeling of convergence and irritation, resulting in problems in use (Patent Document 2; JP-A-10-167940, Patent Document 3; JP-A-2009-155286). ) In particular, there was a problem that the astringent feeling and irritation were strongly expressed after the mouthwash.
従って、液体口腔用組成物において、縮合リン酸塩を配合して使用感を良好に維持しつつ高いステイン付着抑制効果を与えることは難しく、ステイン付着抑制効果の向上が課題であった。
本発明は上記事情に鑑みなされたもので、歯牙のステイン付着抑制効果が向上し、また、収れん感や刺激が抑えられ、特に洗口後の使用感が良好な、澄明性の高い製剤外観を有する液体口腔用組成物を提供することを目的とする。Therefore, in a liquid oral composition, it is difficult to give a high stain adhesion inhibitory effect while blending a condensed phosphate and maintaining a good feeling in use, and improvement of the stain adhesion inhibitory effect has been a problem.
The present invention has been made in view of the above circumstances, and the effect of inhibiting the adhesion of stains to teeth has been improved. Also, the feeling of convergence and irritation can be suppressed, and the use appearance after mouth washing is particularly good, and the formulation has a clear appearance. It aims at providing the composition for liquid oral cavity which has.
本発明者らは、上記目的を達成するため鋭意検討を行った結果、(A)縮合リン酸塩に、(B)ヒドロキシアルキルセルロース、(C)アシルサルコシン塩及び(D)ノニオン性界面活性剤を併用して液体口腔用組成物に配合すると、歯牙のステイン付着抑制効果が高まり、また、縮合リン酸由来の収れん感や刺激が抑えられ、適用後に口腔内がべたつくことがなく、特に洗口後の使用感が良好となり、更に、製剤外観が経時で安定に維持され、澄明性の高い製剤外観を与えることを知見した。 As a result of intensive studies to achieve the above object, the present inventors have found that (B) hydroxyalkyl cellulose, (C) acyl sarcosine salt, and (D) nonionic surfactant are added to (A) condensed phosphate. When combined with a liquid oral composition, the effect of inhibiting the adhesion of stains to teeth is enhanced, the astringent feeling and irritation derived from condensed phosphoric acid is suppressed, and the oral cavity does not become sticky after application. It has been found that the feeling after use becomes good, and further, the appearance of the preparation is stably maintained over time, giving a clear appearance of the preparation.
更に詳述すると、本発明では、液体口腔用組成物において、(A)縮合リン酸塩に(B)ヒドロキシアルキルセルロース及び(C)アシルサルコシン塩を併用することによって、歯牙におけるステインの形成を抑えて付着を抑制する効果が増強するだけでなく、収れん感や刺激を抑えることができる。この場合、(A)、(B)成分を併用すると特に洗口後の口腔内にべたつき感が残るという新たな課題が生じるが、(C)アシルサルコシン塩を配合することで上記べたつき感の課題も解消し、これにより、ステイン付着抑制効果が向上し、かつ使用感が良好な液体製剤を得ることができる。更に、(B)成分と(D)成分を併用することで、高温における澄明外観が安定に維持され、外観安定性が良好な液体製剤を得ることができる。 More specifically, in the present invention, in the liquid oral composition, (B) hydroxyalkyl cellulose and (C) acyl sarcosine salt are used in combination with (A) condensed phosphate to suppress the formation of stains on teeth. In addition to enhancing the effect of suppressing adhesion, it is possible to suppress astringency and irritation. In this case, when the components (A) and (B) are used in combination, a new problem arises that a sticky feeling remains in the oral cavity, particularly after mouth washing. However, the problem of the sticky feeling described above is obtained by adding (C) an acyl sarcosine salt. Accordingly, a liquid preparation with an improved stain adhesion suppressing effect and a good feeling of use can be obtained. Furthermore, by using together the component (B) and the component (D), a clear appearance at a high temperature can be stably maintained, and a liquid preparation with good appearance stability can be obtained.
口腔用組成物において、ヒドロキシアルキルセルロースはセルロース系の粘結剤、アシルサルコシン塩はアニオン性界面活性剤として公知であるが、本発明では、液体口腔用組成物において(A)成分に(B)、(C)及び(D)成分の併用系が特異的に作用し、カルボキシメチルセルロースナトリウム等のセルロース誘導体、あるいは他のアニオン性界面活性剤ではなし得ない格別な作用効果を付与できる。
なお、特許文献4(特開2007−161657号公報)には、水溶性ピロリン酸塩と共にラウリル硫酸ナトリウム及びヒドロキシプロピルメチルセルロースが配合され、歯牙汚れ除去効果が向上し口腔内違和感がない歯磨組成物が提案されているが、これは、発泡性の高いラウリル硫酸ナトリウムが歯牙汚れ除去に寄与する練歯磨等の歯磨組成物の技術であり、本発明とは技術的に相違する。In the oral composition, hydroxyalkyl cellulose is known as a cellulosic binder, and acyl sarcosine salt is known as an anionic surfactant. In the present invention, the liquid oral composition contains (A) component (B). The combined system of components (C) and (D) acts specifically, and can give special effects that cannot be achieved with cellulose derivatives such as sodium carboxymethylcellulose or other anionic surfactants.
Patent Document 4 (Japanese Patent Application Laid-Open No. 2007-161657) includes a dentifrice composition that is formulated with sodium lauryl sulfate and hydroxypropylmethylcellulose together with a water-soluble pyrophosphate, which improves the effect of removing tooth stains and does not cause discomfort in the oral cavity. Although proposed, this is a technique of a dentifrice composition such as toothpaste in which sodium lauryl sulfate having a high foaming property contributes to removal of tooth dirt, and is technically different from the present invention.
従って、本発明は、(A)縮合リン酸塩、(B)ヒドロキシアルキルセルロース、(C)アシルサルコシン塩及び(D)ノニオン性界面活性剤を含有してなることを特徴とする液体口腔用組成物を提供する。 Accordingly, the present invention provides a liquid oral composition comprising (A) a condensed phosphate, (B) a hydroxyalkyl cellulose, (C) an acyl sarcosine salt, and (D) a nonionic surfactant. Offer things.
本発明によれば、歯牙のステイン付着を抑制する効果が向上し、また、収れん感や刺激が抑えられ、適用後の口腔内がべたつくこともなく、特に洗口時の使用感が良好であり、かつ製剤外観が安定で澄明性の高い製剤外観を有する液体口腔用組成物を提供できる。 According to the present invention, the effect of suppressing the adhesion of stains to teeth is improved, the feeling of convergence and irritation are suppressed, the inside of the oral cavity after application is not sticky, and the feeling of use particularly during mouthwashing is good. In addition, it is possible to provide a liquid oral composition having a formulation appearance that is stable and has a clear formulation appearance.
以下、本発明につき更に詳述する。本発明の液体口腔用組成物は、(A)縮合リン酸塩、(B)ヒドロキシアルキルセルロース、(C)アシルサルコシン塩及び(D)ノニオン性界面活性剤を含有する。 The present invention will be described in further detail below. The composition for liquid oral cavity of the present invention contains (A) a condensed phosphate, (B) a hydroxyalkyl cellulose, (C) an acyl sarcosine salt, and (D) a nonionic surfactant.
(A)成分の縮合リン酸塩としては、ピロリン酸、トリポリリン酸、テトラポリリン酸等の直鎖状ポリリン酸、トリメタリン酸、テトラメタリン酸、ヘキサメタリン酸等の環状ポリリン酸のナトリウム塩又はカリウム塩が挙げられる。 As the condensed phosphate of the component (A), linear polyphosphoric acid such as pyrophosphoric acid, tripolyphosphoric acid, tetrapolyphosphoric acid, sodium salt or potassium salt of cyclic polyphosphoric acid such as trimetaphosphoric acid, tetrametaphosphoric acid, hexametaphosphoric acid, etc. Can be mentioned.
縮合リン酸塩は、1種単独で又は2種以上組み合わせて使用できるが、中でもピロリン酸ナトリウム、トリポリリン酸ナトリウムが好ましい。とりわけ、使用感(収れん感や刺激)の改善の点からトリポリリン酸ナトリウムが好ましい。 Condensed phosphates can be used alone or in combination of two or more, among which sodium pyrophosphate and sodium tripolyphosphate are preferred. In particular, sodium tripolyphosphate is preferred from the viewpoint of improving the feeling of use (convergence and irritation).
縮合リン酸塩の配合量は、組成全体の0.1〜2%(質量%、以下同様。)が好ましく、より好ましくは0.2〜2%、更に好ましくは0.2〜1%である。0.1%以上配合することがステイン付着抑制効果の向上に好適である。配合量が多いほどステイン付着抑制効果は高まるが、2%以下であることが使用感(収れん感や刺激)を改善するのに好適である。 The blending amount of the condensed phosphate is preferably 0.1 to 2% (mass%, the same applies hereinafter) of the entire composition, more preferably 0.2 to 2%, and still more preferably 0.2 to 1%. . Mixing 0.1% or more is suitable for improving the stain adhesion inhibiting effect. The greater the amount, the greater the stain adhesion inhibiting effect, but 2% or less is suitable for improving the feeling of use (convergence and irritation).
(B)成分のヒドロキシアルキルセルロースは、縮合リン酸由来の収れん感や刺激を抑え使用感を改善し、また、(D)成分由来の高温安定性低下を抑制し、外観安定性に寄与する。ヒドロキシアルキルセルロースとしては、アルキル基の炭素数が2又は3のものが好ましく、具体的にはヒドロキシエチルセルロース、ヒドロキシプロピルセルロースが挙げられる。特に、縮合リン酸由来の収れん感や刺激を抑え使用感を改善する点、外観安定性の点から、ヒドロキシエチルセルロースが好ましい。 The (B) component hydroxyalkyl cellulose improves the feeling of use by suppressing the astringent feeling and irritation derived from condensed phosphoric acid, and suppresses the high temperature stability decrease derived from the (D) component, thereby contributing to the appearance stability. As the hydroxyalkyl cellulose, those having an alkyl group having 2 or 3 carbon atoms are preferable, and specific examples thereof include hydroxyethyl cellulose and hydroxypropyl cellulose. In particular, hydroxyethyl cellulose is preferred from the viewpoints of suppressing the feeling of convergence and irritation derived from condensed phosphoric acid and improving the feeling of use, and the appearance stability.
(B)成分のヒドロキシアルキルセルロースは、液体口腔用製剤に使用されるものであれば特に制限はない。例えば、ヒドロキシエチルセルロースとしては、1%水溶液での粘度が500〜6,000mPa・sのものが好ましく、より好ましくは1,000〜4,000mPa・sであり、更に好ましくは1,000〜3,000mPa・sである。
ヒドロキシエチルセルロースとして具体的には、ダイセル化学工業(株)からSE600、SE850、SE900、EE820などの製品名で販売されているものが使用できる。
ヒドロキシプロピルセルロースとしては、2%水溶液での粘度が100〜5,000mPa・sのものが好ましく、より好ましくは500〜5,000mPa・s、更に好ましくは1,000〜4,000mPa・sである。
ヒドロキシプロピルセルロースとして具体的には、日本曹達(株)から市販されている商品名Mなどが使用できる。
粘度が上記範囲であることが、効果発現にはより好適である。
なお、粘度の値はB型粘度計(ローターNo.3、30rpm、25℃、1分後の測定値)で測定した。The hydroxyalkyl cellulose as the component (B) is not particularly limited as long as it is used for a liquid oral preparation. For example, as hydroxyethyl cellulose, a 1% aqueous solution having a viscosity of 500 to 6,000 mPa · s is preferable, more preferably 1,000 to 4,000 mPa · s, and still more preferably 1,000 to 3, 000 mPa · s.
Specific examples of hydroxyethyl cellulose include those sold by Daicel Chemical Industries, Ltd. under product names such as SE600, SE850, SE900, and EE820.
Hydroxypropyl cellulose preferably has a viscosity in a 2% aqueous solution of 100 to 5,000 mPa · s, more preferably 500 to 5,000 mPa · s, and still more preferably 1,000 to 4,000 mPa · s. .
Specific examples of hydroxypropylcellulose include the product name M commercially available from Nippon Soda Co., Ltd.
It is more suitable for the effect expression that a viscosity is the said range.
The viscosity value was measured with a B-type viscometer (rotor No. 3, 30 rpm, 25 ° C., measured value after 1 minute).
ヒドロキシアルキルセルロースの配合量は、組成全体の0.05〜0.5%が好ましく、より好ましくは0.05〜0.2%、更に好ましくは0.1〜0.2%である。0.05%以上配合することがステイン付着抑制効果、使用感(縮合リン酸由来の収れん感や刺激の有無)、さらに外観安定性の点で、特に好適である。また、0.5%以下であることが、口腔内のべたつきの点で特に好適である。 The compounding amount of hydroxyalkyl cellulose is preferably 0.05 to 0.5% of the entire composition, more preferably 0.05 to 0.2%, and still more preferably 0.1 to 0.2%. It is particularly preferable to add 0.05% or more from the viewpoint of stain adhesion suppressing effect, feeling of use (condensation feeling or irritation due to condensed phosphoric acid), and appearance stability. Moreover, it is especially suitable from the point of the stickiness in an oral cavity that it is 0.5% or less.
(C)成分のアシルサルコシン塩としては、アシル基の炭素数が10〜18のものが好ましく、また、塩としてはナトリウム等のアルカリ金属塩が好ましい。具体的には、N−ラウロイルサルコシンナトリウム、ミリストイルサルコシンナトリウム、パルミトイルサルコシンナトリウムが好ましく、特に収れん感や刺激の抑制の点からN−ラウロイルサルコシンナトリウム、ミリストイルサルコシンナトリウムが好ましく、とりわけN−ラウロイルサルコシンナトリウムが好ましい。 The acyl sarcosine salt of component (C) is preferably one having an acyl group having 10 to 18 carbon atoms, and the salt is preferably an alkali metal salt such as sodium. Specifically, N-lauroyl sarcosine sodium, myristoyl sarcosine sodium, and palmitoyl sarcosine sodium are preferable, and N-lauroyl sarcosine sodium and myristoyl sarcosine sodium are particularly preferable from the viewpoint of astringency and suppression of irritation, and N-lauroyl sarcosine sodium is particularly preferable. preferable.
アシルサルコシン塩の配合量は、組成全体の0.05〜0.5%が好ましく、より好ましくは0.1〜0.5%、更に好ましくは0.10〜0.3%である。0.05%以上配合することがステイン付着抑制効果を高め、かつ口腔内のべたつき感を改善するのに特に好適である。配合量が多いほどステイン付着抑制効果は高まるが、0.5%以下であることが、使用感(収れん感や刺激)を改善するのに特に好適である。 The compounding amount of the acyl sarcosine salt is preferably 0.05 to 0.5% of the total composition, more preferably 0.1 to 0.5%, and still more preferably 0.10 to 0.3%. Mixing 0.05% or more is particularly suitable for enhancing the stain adhesion suppressing effect and improving the stickiness in the oral cavity. As the blending amount increases, the stain adhesion suppressing effect increases, but 0.5% or less is particularly suitable for improving the feeling of use (convergence and irritation).
本発明では、(A)、(B)、(C)成分を併用することによってステイン付着抑制効果を増強できるが、これら成分を適宜な比率で配合することが、効果発現により好適である。特に、((B)成分+(C)成分)/(A)成分が質量比として0.1〜3であることが好ましく、より好ましくは0.13〜2.17、更に好ましくは0.2〜1.5である。0.1以上であることがステイン付着抑制効果をより向上し、かつ使用感(収れん感や刺激)を改善するのに特に好適であり、3以下であることが、べたつき感を抑えるのに特に好適である。 In the present invention, the stain adhesion inhibitory effect can be enhanced by using the components (A), (B), and (C) in combination, but it is more preferable to blend these components at an appropriate ratio in order to achieve the effect. In particular, the ((B) component + (C) component) / (A) component is preferably 0.1 to 3, more preferably 0.13 to 2.17, and still more preferably 0.2. ~ 1.5. 0.1 or more is particularly suitable for further improving the stain adhesion suppressing effect and improving the feeling of use (convergence and irritation), and 3 or less is particularly suitable for suppressing stickiness. Is preferred.
(D)成分のノニオン性界面活性剤は、(B)成分と併用することで、液体製剤の高温における外観安定性向上に寄与する。ノニオン性界面活性剤としては、ポリオキシエチレン硬化ヒマシ油等のポリオキシエチレン脂肪酸エステル、ショ糖脂肪酸エステル等の糖脂肪酸エステル、糖アルコール脂肪酸エステル、ソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル等が挙げられる。中でも、ポリオキシエチレン硬化ヒマシ油等のポリオキシエチレン脂肪酸エステル、特にエチレンオキサイドの平均付加モル数が40〜100モルのものがより好適である。 Component (D), a nonionic surfactant, contributes to improving the appearance stability of liquid formulations at high temperatures when used in combination with component (B). Nonionic surfactants include polyoxyethylene fatty acid esters such as polyoxyethylene hydrogenated castor oil, sugar fatty acid esters such as sucrose fatty acid esters, sugar alcohol fatty acid esters, sorbitan fatty acid esters, glycerin fatty acid esters, polyglycerin fatty acid esters, Examples include polyoxyethylene sorbitan fatty acid esters. Among them, polyoxyethylene fatty acid esters such as polyoxyethylene hydrogenated castor oil, particularly those having an average added mole number of ethylene oxide of 40 to 100 mol are more preferable.
ノニオン性界面活性剤の配合量は、外観安定性の点から、組成全体の0.3%以上が好ましく、より好ましくは0.5%以上、更に好ましくは0.8%以上である。また、使用感(べたつきのなさ)の点から、組成全体の1.5%以下とすることが好ましく、1.2%以下がより好ましい。前記下限値以上とすると、例えば油性成分である香料を配合しても、高温での外観安定性が良好であり、好ましい。 The blending amount of the nonionic surfactant is preferably 0.3% or more, more preferably 0.5% or more, and further preferably 0.8% or more of the entire composition from the viewpoint of appearance stability. Moreover, from the point of use feeling (non-stickiness), it is preferable to set it as 1.5% or less of the whole composition, and 1.2% or less is more preferable. When the amount is not less than the lower limit value, for example, even when a perfume that is an oil component is blended, the appearance stability at high temperatures is good, which is preferable.
本発明の液体口腔用組成物の粘度は、1〜300mPa・sの範囲とすることが好ましく、特に2〜200mPa・s、とりわけ3〜100mPa・sとすることが、口腔内での製剤の使用感(洗口時の製剤の流動性)の点でより好ましい。なお、粘度はB型粘度計(ローターNo.1、60rpm、25℃、1分後の測定値)で測定した。 The viscosity of the liquid oral composition of the present invention is preferably in the range of 1 to 300 mPa · s, particularly 2 to 200 mPa · s, particularly 3 to 100 mPa · s, and the use of the preparation in the oral cavity. It is more preferable in terms of feeling (fluidity of the preparation at the time of mouth washing). The viscosity was measured with a B-type viscometer (rotor No. 1, 60 rpm, 25 ° C., measured value after 1 minute).
また、本発明の液体口腔用組成物のpHは、口腔内の安全性上問題ない範囲であれば特に限定されず、pH5.5〜9.0の範囲でよい。 In addition, the pH of the liquid oral composition of the present invention is not particularly limited as long as it is in a range that does not cause problems in the oral cavity, and may be in the range of pH 5.5 to 9.0.
本発明の液体口腔用組成物は、特に洗口剤、液体歯磨剤等の液体製剤として好適に調製される。また、上記成分に加えて、剤型に応じた適宜な公知成分を本発明の効果を妨げない範囲で配合することができる。例えば湿潤剤、増粘剤、界面活性剤、更には必要により甘味剤、防腐剤、香料、着色剤、有効成分、pH調整剤等を配合できる。なお、本発明の液体口腔用組成物は、澄明な外観とする点から、懸濁成分である研磨剤等の水不溶性粉体は無配合とすることが好ましい。 The liquid oral cavity composition of the present invention is particularly suitably prepared as a liquid preparation such as a mouthwash and a liquid dentifrice. Moreover, in addition to the said component, the appropriate well-known component according to a dosage form can be mix | blended in the range which does not inhibit the effect of this invention. For example, a wetting agent, a thickening agent, a surfactant, and a sweetener, an antiseptic, a fragrance, a colorant, an active ingredient, a pH adjuster, and the like can be blended if necessary. In addition, it is preferable not to mix | blend water-insoluble powders, such as an abrasive | polishing agent which is a suspension component, from the point which makes the liquid oral composition of this invention a clear external appearance.
湿潤剤としては、ソルビトール等の糖アルコール、グリセリン、プロピレングリコール、ポリエチレングリコール等の多価アルコールが挙げられる。これら湿潤剤は組成全体の2〜20%配合できる。 Examples of the wetting agent include sugar alcohols such as sorbitol, and polyhydric alcohols such as glycerin, propylene glycol, and polyethylene glycol. These wetting agents can be blended in 2 to 20% of the total composition.
増粘剤としては、ヒドロキシアルキルセルロース以外のキサンタンガム、カラギーナン等が挙げられ、配合量は0〜2%が好ましい。 Examples of the thickener include xanthan gum and carrageenan other than hydroxyalkyl cellulose, and the blending amount is preferably 0 to 2%.
任意の界面活性剤としては、アシルサルコシン塩以外のアニオン性界面活性剤、カチオン性界面活性剤、両性界面活性剤が挙げられる。 Optional surfactants include anionic surfactants other than acyl sarcosine salts, cationic surfactants, and amphoteric surfactants.
アニオン性界面活性剤としては、ラウリル硫酸ナトリウム、ミリスチル硫酸ナトリウム等のアルキル硫酸塩、ドデシルベンゼンスルホン酸ナトリウム、水素添加ココナッツ脂肪酸モノグリセリドモノ硫酸ナトリウム、ラウリルスルホ酢酸ナトリウム、N−パルミトイルグルタミン酸ナトリウム等のN−アシルグルタミン酸塩、N−メチル−N−アシルタウリンナトリウム、N−メチル−N−アシルアラニンナトリウム、α−オレフィンスルフォン酸ナトリウムなどが挙げられる。前記(C)成分以外のアニオン性界面活性剤の配合量は、組成全体の0〜0.2%が好ましく、より好ましくは0〜0.1%、更に好ましくは0〜0.05%である。(C)成分以外のアニオン性界面活性剤、特にアルキル硫酸塩を前記上限値以下とすると、特に口腔内刺激が低い液体口腔用組成物が得られるため好ましい。任意のアニオン性界面活性剤の添加は最小限にすることが好ましく、配合しないことがより好ましい。
カチオン性界面活性剤としては、アルキルアンモニウム、アルキルベンジルアンモニウム塩等が挙げられる。カチオン性界面活性剤の配合量は、組成全体の0〜5%が好ましく、より好ましくは0〜3%である。両性界面活性剤としては、アルキルジメチルアミノ酢酸ベタイン等の酢酸ベタイン型、イミダゾリン型の界面活性剤が挙げられる。両性界面活性剤の配合量は、組成全体の0〜5%が好ましく、より好ましくは0〜3%である。
これらの(C)、(D)成分以外の任意の界面活性剤の配合量は、組成全体の0〜5%、特に0.05〜5%が好ましい。Examples of the anionic surfactant include alkyl sulfates such as sodium lauryl sulfate and sodium myristyl sulfate, sodium dodecylbenzene sulfonate, hydrogenated coconut fatty acid sodium monoglyceride monosulfate, sodium lauryl sulfoacetate, sodium N-palmitoyl glutamate and the like N- Examples include acyl glutamate, sodium N-methyl-N-acyl taurate, sodium N-methyl-N-acylalanine, sodium α-olefin sulfonate, and the like. The amount of the anionic surfactant other than the component (C) is preferably 0 to 0.2%, more preferably 0 to 0.1%, still more preferably 0 to 0.05% of the total composition. . It is preferable to use an anionic surfactant other than the component (C), particularly an alkyl sulfate, below the upper limit because a liquid oral composition with particularly low oral irritation can be obtained. The addition of any anionic surfactant is preferably minimized and more preferably not added.
Examples of the cationic surfactant include alkyl ammonium and alkyl benzyl ammonium salts. 0-5% of the whole composition is preferable, and, as for the compounding quantity of a cationic surfactant, More preferably, it is 0-3%. Examples of amphoteric surfactants include betaine acetate type and imidazoline type surfactants such as alkyldimethylaminoacetic acid betaine. The amount of amphoteric surfactant is preferably 0 to 5%, more preferably 0 to 3% of the total composition.
The blending amount of any surfactant other than these components (C) and (D) is preferably 0 to 5%, particularly preferably 0.05 to 5% of the entire composition.
甘味剤としては、キシリトール、サッカリンナトリウム等が挙げられる。防腐剤としては安息香酸又はその塩、パラオキシ安息香酸エステル等が挙げられる。
香料としては、通常用いられる周知の香料を適宜配合することができ、例えばペパーミント油、スペアミント油、ハッカ油等の天然香料、l−メントール、カルボン、アネトール等の単品香料、更に単品香料、天然香料を含む調合香料などが挙げられる。香料は、1種又は2種以上を組成中0.00001〜3%配合することが好ましい。
着色剤として、黄色4号、赤色106号、青色1号、緑色3号などの安全性が高い水溶性色素を添加することができる。Examples of sweeteners include xylitol and sodium saccharin. Examples of the preservative include benzoic acid or a salt thereof, paraoxybenzoic acid ester and the like.
As the fragrance, well-known fragrances that are usually used can be appropriately blended. For example, natural fragrances such as peppermint oil, spearmint oil, and mint oil, single fragrances such as l-menthol, carvone and anethole, and further single fragrances and natural fragrances. For example, a blended fragrance containing It is preferable to mix | blend a fragrance | flavor 1 type (s) or 2 or more types in the composition 0.000013%.
As a colorant, water-soluble pigments having high safety such as yellow No. 4, red No. 106, blue No. 1, and green No. 3 can be added.
有効成分としては、縮合リン酸塩以外のもの、例えばイソプロピルメチルフェノール等の非イオン性殺菌剤、塩化セチルピリジニウム、塩化ベンゼトニウム等のカチオン性殺菌剤、トラネキサム酸、イプシロンアミノカプロン酸、グリチルレチン酸、グリチルリチン酸等の抗炎症剤、デキストラナーゼ、ムタナーゼ等の酵素、フッ化ナトリウム、モノフルオロリン酸ナトリウム等のフッ化物、グルコン酸銅、銅クロロフィリンナトリウム等の銅化合物、塩化ナトリウム、硝酸カリウム、乳酸アルミニウム、塩化亜鉛、クエン酸亜鉛等の無機塩類、アスコルビン酸、酢酸トコフェロール等のビタミン類、アズレン、ジヒドロコレステロール、クロロフィル、トウキ軟エキス、タイム、オウゴン、チョウジ、ハマメリス等の植物抽出物などが挙げられる。なお、上記有効成分は、本発明の効果を妨げない範囲で有効量配合できる。 Active ingredients include those other than condensed phosphates, for example, nonionic fungicides such as isopropylmethylphenol, cationic fungicides such as cetylpyridinium chloride, benzethonium chloride, tranexamic acid, epsilon aminocaproic acid, glycyrrhetinic acid, glycyrrhizic acid Anti-inflammatory agents such as dextranase and mutanase, fluorides such as sodium fluoride and sodium monofluorophosphate, copper compounds such as copper gluconate and copper chlorophyllin sodium, sodium chloride, potassium nitrate, aluminum lactate and chloride Examples include inorganic salts such as zinc and zinc citrate, vitamins such as ascorbic acid and tocopherol acetate, plant extracts such as azulene, dihydrocholesterol, chlorophyll, soft extract of thyme, thyme, ogon, clove, and hamamelis It is. In addition, the said active ingredient can be mix | blended in an effective amount in the range which does not prevent the effect of this invention.
pH調整剤としては、適宜な公知のpH調整剤を使用でき、例えばリン酸、クエン酸やそれらのナトリウム塩などが挙げられる。25℃における組成物pHを5.5〜9.0に調整するのに好適なpH調整剤として、リン酸二水素ナトリウムとリン酸一水素ナトリウム、あるいはクエン酸とクエン酸ナトリウムの組み合わせが好ましい。
溶剤としては、精製水が一般的に用いられるが、エタノール等の低級一価アルコールを0〜10%、特に1〜8%、とりわけ3〜7%程度配合してもよい。As the pH adjuster, an appropriate known pH adjuster can be used, and examples thereof include phosphoric acid, citric acid, and sodium salts thereof. As a pH adjusting agent suitable for adjusting the composition pH at 25 ° C. to 5.5 to 9.0, sodium dihydrogen phosphate and sodium monohydrogen phosphate, or a combination of citric acid and sodium citrate is preferable.
As the solvent, purified water is generally used, but a lower monohydric alcohol such as ethanol may be blended in an amount of 0 to 10%, particularly 1 to 8%, especially 3 to 7%.
本発明組成物は、特に洗口剤等の液体製剤として調製し、口中に含んで10〜30秒間、特に15〜20秒間、口中をすすぐことで好適に適用できる。更に、歯ブラシでブラッシングしてもよい。 The composition of the present invention can be suitably applied by preparing a liquid preparation such as a mouthwash, and rinsing the mouth for 10 to 30 seconds, particularly 15 to 20 seconds. Furthermore, you may brush with a toothbrush.
以下、実施例及び比較例を示し、本発明を具体的に説明するが、本発明は下記の実施例に制限されるものではない。なお、下記の例において%は特に断らない限りいずれも質量%を示す。 EXAMPLES Hereinafter, although an Example and a comparative example are shown and this invention is demonstrated concretely, this invention is not restrict | limited to the following Example. In the following examples, “%” means “% by mass” unless otherwise specified.
[実施例、比較例]
表1〜4に示す組成の液体口腔用組成物(洗口剤)を下記方法で調製し、得られた製剤をサンプルとして下記の評価を行った。結果を表に併記する。[Examples and Comparative Examples]
The liquid oral composition (mouthwash) of the composition shown in Tables 1-4 was prepared by the following method, and the following evaluation was performed using the obtained preparation as a sample. The results are shown in the table.
<口腔用組成物の調製方法>
表1〜4の組成に応じ、精製水中に水溶性原料(ノニオン性界面活性剤を除く)を溶解した後、エタノール及び/又は多価アルコールに油溶性原料とノニオン性界面活性剤を溶解した液を、攪拌しながら加え、均一溶解させた。なお、製造にはスリーワンモーター(BL1200、HEIDON社製)を用いた。得られた本発明品の粘度は、何れも5〜60mPa・sであった。なお、比較例は上記方法に準じて調製した。<Method for Preparing Oral Composition>
A solution in which an oil-soluble raw material and a nonionic surfactant are dissolved in ethanol and / or polyhydric alcohol after dissolving a water-soluble raw material (excluding nonionic surfactant) in purified water according to the composition of Tables 1 to 4. Was added with stirring to achieve uniform dissolution. A three-one motor (BL1200, manufactured by HEIDON) was used for manufacturing. The viscosity of the obtained product of the present invention was 5 to 60 mPa · s. In addition, the comparative example was prepared according to the said method.
<ステイン付着抑制効果の評価方法>
1.タンニン液の調製
沸騰した蒸留水1Lに10gの緑茶葉(農家の自家出し茶980、株式会社伊藤園製)を含むティーパックを5袋投入し、さらに紅茶ティーバック(日東紅茶デイリークラブ、三井農林株式会社製)を5袋投入し、一晩抽出した。その後、インスタントコーヒー(ネスレインスタントコーヒー、ネスレ日本株式会社製)を12g加え攪拌後、1,200mLにメスアップした。
2.アルブミン液の調製
蒸留水1,200mLにアルブミン(ウシ血清由来、pH5.2、和光純薬工業株式会社製)を6.0g溶解させた。
3.塩化第二鉄液の調製
蒸留水1,200mLにクエン酸アンモニウム鉄(III)(関東化学株式会社製)を6.85g溶解させた。<Evaluation method of stain adhesion inhibitory effect>
1. Preparation of tannin solution Add 5 bags of tea pack containing 10g of green tea leaves (Farmer's home-grown tea 980, made by ITO EN Co., Ltd.) to 1L of boiling distilled water, and tea tea bags (Nitto Tea Daily Club, Mitsui Norin Co., Ltd.) 5 bags (made by company) were put in and extracted overnight. Thereafter, 12 g of instant coffee (Nestlé Instant Coffee, manufactured by Nestlé Japan Co., Ltd.) was added and stirred, and the volume was increased to 1,200 mL.
2. Preparation of albumin solution 6.0 g of albumin (derived from bovine serum, pH 5.2, manufactured by Wako Pure Chemical Industries, Ltd.) was dissolved in 1,200 mL of distilled water.
3. Preparation of ferric chloride solution 6.85 g of ammonium iron (III) citrate (manufactured by Kanto Chemical Co., Inc.) was dissolved in 1,200 mL of distilled water.
4.ハイドロキシアパタイト(HA)ディスクを用いたステイン付着抑制効果の評価
被試験面を#1,500のサンドペーパーで研磨したHAディスク(APP−735;ペンタックス株式会社製)の初期のHAの色度を測色色差計(CM2002、コニカミノルタ株式会社製)にて測定した。次に、このHAディスクを、表1〜4に示したサンプルに50℃で30秒間浸漬させ、その後アルブミン液に10分間、タンニン液に10分間、塩化第二鉄液に10分間順次浸漬後、水で洗浄し、この工程を計12回繰り返し、HAディスクの色度を測色色差計にて測定した。L*a*b*表色系のΔE値から下記式によりステイン付着抑制率を算出した。なお、式中、コントロールは、初期の色度を測定したHAディスクを、サンプルの代わりに精製水を用いて上記と同様の一連の操作を行ったものであり、このHAディスクの色度を測色色差計にて測定して同様にΔE値を求めた。4). Evaluation of Stain Adhesion Suppression Effect Using Hydroxyapatite (HA) Disc Measure the initial HA chromaticity of a HA disc (APP-735; manufactured by Pentax Co., Ltd.) whose surface to be tested was polished with # 1,500 sandpaper. It measured with the color difference meter (CM2002, Konica Minolta Co., Ltd. make). Next, this HA disk was immersed in the samples shown in Tables 1 to 4 at 50 ° C. for 30 seconds, then sequentially immersed in albumin solution for 10 minutes, tannin solution for 10 minutes, and ferric chloride solution for 10 minutes, This process was repeated 12 times in total, and the chromaticity of the HA disk was measured with a colorimetric color difference meter. From the ΔE value of the L * a * b * color system, the stain adhesion inhibition rate was calculated by the following formula. In the formula, the control was obtained by performing a series of operations similar to the above on the HA disk whose initial chromaticity was measured using purified water instead of the sample, and measuring the chromaticity of this HA disk. The ΔE value was similarly determined by measuring with a color difference meter.
ステイン付着抑制効果の評価基準
一連の実験操作は各実施例及び比較例につきN=3で行い、各例のステイン付着抑制率の平均値を算出し、下記の評価基準にてステイン除去効果を評価した。
◎:ステイン付着抑制率が80%以上100%以下
○:ステイン付着抑制率が60%以上80%未満
△:ステイン付着抑制率が30%以上60%未満
×:ステイン付着抑制率が30%未満Evaluation Criteria for Stain Adhesion Suppression Effect A series of experimental operations were performed with N = 3 for each Example and Comparative Example, and the average value of the stain adhesion inhibition rate of each example was calculated, and the stain removal effect was evaluated by the following evaluation criteria did.
◎: Stain adhesion inhibition rate is 80% or more and 100% or less ○: Stain adhesion inhibition rate is 60% or more and less than 80% △: Stain adhesion inhibition rate is 30% or more and less than 60% ×: Stain adhesion inhibition rate is less than 30%
<使用感(収れん感や刺激のなさ)の評価方法>
表1〜4に示したサンプル10mLを口に含み、30秒間口をすすいで吐出した後の使用感(収れん感や刺激のなさ)について下記の5段階で評価し、パネラー5名の平均点を次の基準に従い◎、○、△、×で表に示した。
使用感の評価基準
5:収れん感や刺激を感じない
4:収れん感や刺激をほとんど感じない
3:収れん感や刺激をわずかに感じるが問題ないレベルである
2:収れん感や刺激をやや感じる
1:収れん感や刺激を感じる
使用感の判定基準
◎:平均点4.0点以上5.0点以下
○:平均点3.0点以上4.0点未満
△:平均点2.0点以上3.0点未満
×:平均点2.0点未満<Evaluation method of feeling of use (feeling of convergence and lack of irritation)>
Evaluate the feeling of use (no astringency or irritation) after rinsing the mouth for 30 seconds, including the 10 mL sample shown in Tables 1 to 4 in the following five stages, and the average score of the five panelists According to the following criteria, it is shown in the table with ◎, ○, Δ, ×.
Evaluation criteria for feeling of use 5: Feeling no convergence or irritation 4: Feeling little astringency or irritation 3: Slight astringency or irritation, but no problem 2: Feeling astringency or irritation a little 1 : Judgment criteria for feeling of convergence and irritation ◎: Average point 4.0 to 5.0 points ○: Average point 3.0 to less than 4.0 points △: Average point 2.0 to 3 Less than 0 point x: Average point less than 2.0 point
<べたつき感の評価方法>
表1〜4に示したサンプル10mLを口に含み、30秒間口をすすいで吐出した後の口腔内のべたつき感のなさについて下記の5段階で評価し、パネラー5名の平均点を次の基準に従い◎、○、△、×で表に示した。
べたつき感のなさの評価基準
5:べたつき感がない
4:べたつき感がほとんどない
3:べたつき感がわずかにあるが問題ないレベルである
2:べたつき感がある
1:べたつき感が強くある
べたつき感のなさの判定基準
◎:平均点4.0点以上5.0点以下
○:平均点3.0点以上4.0点未満
△:平均点2.0点以上3.0点未満
×:平均点2.0点未満<Evaluation method for stickiness>
In the mouth, containing 10 mL of the sample shown in Tables 1 to 4, and evaluating the absence of stickiness in the oral cavity after rinsing the mouth for 30 seconds, the average score of the five panelists was evaluated according to the following criteria: The results are shown in the table with ◎, ○, Δ, ×.
Evaluation criteria for non-stickiness 5: No stickiness 4: Little stickiness 3: Slightly sticky but no problem 2: Stickiness 1: Strong stickiness Judgment Criteria ◎: Average point 4.0 point to 5.0 point ○: Average point 3.0 point to less than 4.0 point △: Average point 2.0 point to less than 3.0 point ×: Average point Less than 2.0
<外観安定性の評価方法>
表1〜4に示したサンプルを満注量90mLの無色透明なPET容器に80mL充填し、50℃1ヶ月保存後のニゴリを下記基準に則り目視判定した。なお、◎又は○であるものを、外観が安定に維持され澄明性が高い製剤外観であると判断した。
ニゴリ評価基準
◎:ニゴリが全くない。精製水を充填したPET容器と比較しても全くニ
ゴリが認められない。
○:精製水を充填したPET容器と比較して僅かにニゴリが認められるが
、比較がなければ判別できないレベルであり、問題ない。
△:精製水を充填したPET容器と比較して明らかにニゴリが認められ、
比較がなくてもややニゴリが認められる
×:精製水を充填したPET容器と比較しなくても明らかにニゴリが認め
られ、PET容器の向こう側を透かし見るのが困難な程、濁っている
。<Appearance stability evaluation method>
The samples shown in Tables 1 to 4 were filled in 80 mL of a colorless and transparent PET container having a full injection amount of 90 mL, and the determination after storage at 50 ° C. for 1 month was visually determined according to the following criteria. In addition, what was (double-circle) or (circle) was judged that it was a formulation external appearance with the appearance maintained stably and high clarity.
Nigori evaluation criteria A: There is no negligible. Even if compared with a PET container filled with purified water, no abnormality is observed.
○: Slight scratching is observed compared to a PET container filled with purified water, but there is no problem because it is a level that cannot be determined without comparison.
Δ: Slightly recognized as compared with a PET container filled with purified water,
Even if there is no comparison, a slight stain is observed. ×: A clear stain is recognized without comparison with a PET container filled with purified water, and it is so cloudy that it is difficult to see through the other side of the PET container.
なお、使用原料の詳細は下記のとおりである。
トリポリリン酸ナトリウム;太平化学産業(株)製
ピロリン酸ナトリウム;太平化学産業(株)製
ヒドロキシエチルセルロース;ダイセル化学工業(株)製、EE820、粘度1,300〜2,100mPa・s(1%水溶液、25℃)
ヒドロキシプロピルセルロース;日本曹達(株)製、H、粘度1,000〜4,000mPa・s(2%水溶液、20℃)
N−ラウロイルサルコシンナトリウム;旭硝子(株)製
ミリストイルサルコシンナトリウム;太平化学産業(株)製
パルミトイルサルコシンナトリウム;太平化学産業(株)製
ポリオキシエチレン硬化ヒマシ油;日本エマルジョン(株)製、なお、( )内の数値はエチレンオキサイドの平均付加モル数である。The details of the raw materials used are as follows.
Sodium tripolyphosphate; sodium pyrophosphate manufactured by Taihei Chemical Industry Co., Ltd .; hydroxyethyl cellulose manufactured by Taihei Chemical Industry Co., Ltd .; manufactured by Daicel Chemical Industries, Ltd., EE820, viscosity 1,300-2,100 mPa · s (1% aqueous solution, 25 ° C)
Hydroxypropyl cellulose; manufactured by Nippon Soda Co., Ltd., H, viscosity 1,000 to 4,000 mPa · s (2% aqueous solution, 20 ° C.)
N-lauroyl sarcosine sodium; Asahi Glass Co., Ltd. Myristoyl sarcosine sodium; Taihei Chemical Industrial Co., Ltd. Palmitoyl sarcosine sodium; Taihei Chemical Industrial Co., Ltd. polyoxyethylene hydrogenated castor oil; Nippon Emulsion Co., Ltd. The numerical value in parentheses is the average added mole number of ethylene oxide.
また、上記と同様に上記使用原料を用いて下記実施例の液体口腔用組成物を調製し、ステイン付着抑制効果、使用感、べたつき感及び外観安定性について同様に評価したところ、全て優れていた。 Moreover, the liquid oral cavity compositions of the following examples were prepared using the above-mentioned raw materials in the same manner as described above, and the stain adhesion inhibitory effect, feeling of use, stickiness and appearance stability were similarly evaluated. .
[実施例26] 洗口剤
(A)トリポリリン酸ナトリウム 0.5%
(B)ヒドロキシエチルセルロース 0.15
(C)N−ラウロイルサルコシンナトリウム 0.15
(D)ポリオキシエチレン(60)硬化ヒマシ油 0.9
イソプロピルメチルフェノール 0.04
ε−アミノカプロン酸 0.06
グリセリン 2
プロピレングリコール 4
ポリエチレングリコール(400) 3
リン酸一水素ナトリウム 0.6
リン酸二水素ナトリウム 0.1
パラオキシ安息香酸メチル 0.1
サッカリンナトリウム 0.01
香料A 0.2
水 残
計 100.0%
((B)+(C))/(A)=0.60[Example 26] Mouthwash (A) sodium tripolyphosphate 0.5%
(B) Hydroxyethyl cellulose 0.15
(C) Sodium N-lauroyl sarcosine 0.15
(D) Polyoxyethylene (60) hydrogenated castor oil 0.9
Isopropylmethylphenol 0.04
ε-aminocaproic acid 0.06
Glycerin 2
Propylene glycol 4
Polyethylene glycol (400) 3
Sodium monohydrogen phosphate 0.6
Sodium dihydrogen phosphate 0.1
Methyl paraoxybenzoate 0.1
Saccharin sodium 0.01
Fragrance A 0.2
Water remaining
Total 100.0%
((B) + (C)) / (A) = 0.60
[実施例27] 洗口剤
(A)ピロリン酸ナトリウム 0.3%
(B)ヒドロキシエチルセルロース 0.2
(C)パルミトイルサルコシンナトリウム 0.1
(D)ポリオキシエチレン(100)硬化ヒマシ油 0.5
塩化セチルピリジニウム 0.05
トラネキサム酸 0.05
グリセリン 5
プロピレングリコール 4
キシリトール 2
安息香酸ナトリウム 0.2
リン酸一水素ナトリウム 0.7
リン酸二水素ナトリウム 0.1
香料B 0.2
水 残
計 100.0%
((B)+(C))/(A)=1.00Example 27 Mouthwash (A) Sodium pyrophosphate 0.3%
(B) Hydroxyethyl cellulose 0.2
(C) Palmitoyl sarcosine sodium 0.1
(D) Polyoxyethylene (100) hydrogenated castor oil 0.5
Cetylpyridinium chloride 0.05
Tranexamic acid 0.05
Glycerin 5
Propylene glycol 4
Xylitol 2
Sodium benzoate 0.2
Sodium monohydrogen phosphate 0.7
Sodium dihydrogen phosphate 0.1
Fragrance B 0.2
Water remaining
Total 100.0%
((B) + (C)) / (A) = 1.00
[実施例28] 洗口剤
(A)トリポリリン酸ナトリウム 0.3%
(B)ヒドロキシプロピルセルロース 0.2
(C)ミリストイルサルコシンナトリウム 0.2
(D)ポリオキシエチレン(60)硬化ヒマシ油 0.9
グリセリン 9
プロピレングリコール 3
キシリトール 2
安息香酸ナトリウム 0.3
パラオキシ安息香酸メチル 0.1
リン酸一水素ナトリウム 0.8
リン酸二水素ナトリウム 0.2
緑色3号 微量
黄色4号 微量
香料C 0.3
水 残
計 100.0%
((B)+(C))/(A)=1.33Example 28 Mouthwash (A) Sodium tripolyphosphate 0.3%
(B) Hydroxypropyl cellulose 0.2
(C) Myristoyl sarcosine sodium 0.2
(D) Polyoxyethylene (60) hydrogenated castor oil 0.9
Glycerin 9
Propylene glycol 3
Xylitol 2
Sodium benzoate 0.3
Methyl paraoxybenzoate 0.1
Sodium monohydrogen phosphate 0.8
Sodium dihydrogen phosphate 0.2
Green No. 3 Trace Yellow No. 4 Trace Fragrance C 0.3
Water remaining
Total 100.0%
((B) + (C)) / (A) = 1.33
[実施例29] 洗口剤
(A)ピロリン酸ナトリウム 0.3%
(B)ヒドロキシエチルセルロース 0.1
(C)N−ラウロイルサルコシンナトリウム 0.1
(D)ポリオキシエチレン(80)硬化ヒマシ油 0.8
グリセリン 7
プロピレングリコール 4
キシリトール 3
安息香酸ナトリウム 0.5
パラオキシ安息香酸エチル 0.1
リン酸一水素ナトリウム 0.7
リン酸二水素ナトリウム 0.1
赤色106号 微量
黄色4号 微量
香料D 0.4
水 残
計 100.0%
((B)+(C))/(A)=0.67[Example 29] Mouthwash (A) Sodium pyrophosphate 0.3%
(B) Hydroxyethyl cellulose 0.1
(C) N-lauroyl sarcosine sodium 0.1
(D) Polyoxyethylene (80) hydrogenated castor oil 0.8
Glycerin 7
Propylene glycol 4
Xylitol 3
Sodium benzoate 0.5
Ethyl paraoxybenzoate 0.1
Sodium monohydrogen phosphate 0.7
Sodium dihydrogen phosphate 0.1
Red No. 106 Trace Yellow No. 4 Trace Fragrance D 0.4
Water remaining
Total 100.0%
((B) + (C)) / (A) = 0.67
[実施例30] 洗口剤
(A)トリポリリン酸ナトリウム 0.4%
(B)ヒドロキシエチルセルロース 0.1
(C)パルミトイルサルコシンナトリウム 0.3
(D)ポリオキシエチレン(80)硬化ヒマシ油 1.2
フッ化ナトリウム 0.05
グリセリン 5
プロピレングリコール 2
キシリトール 3
安息香酸ナトリウム 0.3
パラオキシ安息香酸エチル 0.1
リン酸一水素ナトリウム 0.6
リン酸二水素ナトリウム 0.1
青色1号 微量
黄色4号 微量
香料E 0.3
水 残
計 100.0%
((B)+(C))/(A)=1.00[Example 30] Mouthwash (A) sodium tripolyphosphate 0.4%
(B) Hydroxyethyl cellulose 0.1
(C) Palmitoyl sarcosine sodium 0.3
(D) Polyoxyethylene (80) hydrogenated castor oil 1.2
Sodium fluoride 0.05
Glycerin 5
Propylene glycol 2
Xylitol 3
Sodium benzoate 0.3
Ethyl paraoxybenzoate 0.1
Sodium monohydrogen phosphate 0.6
Sodium dihydrogen phosphate 0.1
Blue No. 1 Trace Yellow No. 4 Trace Fragrance E 0.3
Water remaining
Total 100.0%
((B) + (C)) / (A) = 1.00
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014518421A JP6217628B2 (en) | 2012-05-28 | 2013-05-24 | Mouthwash |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012120488 | 2012-05-28 | ||
JP2012120488 | 2012-05-28 | ||
PCT/JP2013/064435 WO2013180019A1 (en) | 2012-05-28 | 2013-05-24 | Liquid oral composition |
JP2014518421A JP6217628B2 (en) | 2012-05-28 | 2013-05-24 | Mouthwash |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2013180019A1 true JPWO2013180019A1 (en) | 2016-01-21 |
JP6217628B2 JP6217628B2 (en) | 2017-10-25 |
Family
ID=49673215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014518421A Active JP6217628B2 (en) | 2012-05-28 | 2013-05-24 | Mouthwash |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP6217628B2 (en) |
KR (1) | KR101821627B1 (en) |
CN (1) | CN104363881B (en) |
WO (1) | WO2013180019A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019199466A (en) * | 2018-05-15 | 2019-11-21 | アース製薬株式会社 | Liquid oral composition and oral washing method |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6441669B2 (en) * | 2014-12-26 | 2018-12-19 | 花王株式会社 | Liquid oral composition |
EP3368163B1 (en) * | 2015-10-26 | 2022-08-17 | Colgate-Palmolive Company | Mouthwash products and methods |
JP6742339B2 (en) * | 2015-12-14 | 2020-08-19 | 花王株式会社 | Liquid oral composition |
MY200178A (en) * | 2016-09-02 | 2023-12-12 | Lion Corp | Oral composition |
JP2018052886A (en) * | 2016-09-29 | 2018-04-05 | 小林製薬株式会社 | Aqueous formulation |
JP6939096B2 (en) * | 2017-05-31 | 2021-09-22 | ライオン株式会社 | Liquid oral composition |
BE1025996A9 (en) * | 2018-01-19 | 2020-05-11 | Hyloris Dev Sa | ORAL TRANEXAMIC ACID SOLUTION |
KR102704053B1 (en) * | 2024-01-11 | 2024-09-09 | 악어새플래닛 주식회사 | Manufacturing method of toothpaste composition including ingredient of improving oral dryness |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05262628A (en) * | 1992-03-17 | 1993-10-12 | Sunstar Inc | Transparent liquid composition for oral cavity application |
JP2000281549A (en) * | 1999-03-29 | 2000-10-10 | Lion Corp | Dentifrice composition |
JP2012046433A (en) * | 2010-08-25 | 2012-03-08 | Kao Corp | Liquid composition for oral cavity |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03200714A (en) * | 1989-12-27 | 1991-09-02 | Lion Corp | Composition for oral cavity application |
JP4109727B2 (en) * | 1996-07-05 | 2008-07-02 | サンスター株式会社 | Composition for oral cavity containing amino acid surfactant |
CN100534413C (en) * | 2001-12-25 | 2009-09-02 | 花王株式会社 | Compositions for mouth |
JP4482767B2 (en) * | 2003-06-27 | 2010-06-16 | ライオン株式会社 | Dentifrice composition |
CN101690699A (en) * | 2009-09-29 | 2010-04-07 | 广东名臣有限公司 | Teeth-cleaning whitening toothpaste composition |
-
2013
- 2013-05-24 KR KR1020147022359A patent/KR101821627B1/en active IP Right Grant
- 2013-05-24 JP JP2014518421A patent/JP6217628B2/en active Active
- 2013-05-24 WO PCT/JP2013/064435 patent/WO2013180019A1/en active Application Filing
- 2013-05-24 CN CN201380028694.3A patent/CN104363881B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05262628A (en) * | 1992-03-17 | 1993-10-12 | Sunstar Inc | Transparent liquid composition for oral cavity application |
JP2000281549A (en) * | 1999-03-29 | 2000-10-10 | Lion Corp | Dentifrice composition |
JP2012046433A (en) * | 2010-08-25 | 2012-03-08 | Kao Corp | Liquid composition for oral cavity |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019199466A (en) * | 2018-05-15 | 2019-11-21 | アース製薬株式会社 | Liquid oral composition and oral washing method |
Also Published As
Publication number | Publication date |
---|---|
WO2013180019A1 (en) | 2013-12-05 |
KR20150023219A (en) | 2015-03-05 |
JP6217628B2 (en) | 2017-10-25 |
CN104363881A (en) | 2015-02-18 |
KR101821627B1 (en) | 2018-01-24 |
CN104363881B (en) | 2017-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6217628B2 (en) | Mouthwash | |
JP6270659B2 (en) | Stain adhesion inhibitor and oral composition | |
JP7173043B2 (en) | Oral stain remover, oral stain formation inhibitor, and oral composition | |
WO2013094504A1 (en) | Oral composition | |
CN106659656B (en) | Oral composition | |
JP5842565B2 (en) | Mouthwash composition and method for inhibiting discoloration in mouthwash composition | |
JP2006347986A (en) | Composition for oral cavity | |
JP6610208B2 (en) | Oral composition | |
JP5948903B2 (en) | Dentifrice composition and method for improving antiseptic power of dentifrice composition | |
JP2013129621A (en) | Composition for oral cavity | |
JP7172028B2 (en) | oral composition | |
JP5845603B2 (en) | Liquid or liquid oral composition and tongue coating adhesion inhibitor | |
JP6693504B2 (en) | Dentifrice composition | |
JPWO2018043717A1 (en) | Oral composition | |
JP2020097556A (en) | Oral composition | |
JP2016141661A (en) | Oral composition | |
JP6618508B2 (en) | Method for preventing adhesion of pigment to tooth or plaque and pigment adhesion inhibitor | |
JP2020097557A (en) | Oral composition | |
JP6439425B2 (en) | Liquid oral composition | |
JP2022131331A (en) | Method for inhibiting deposition of insoluble substance in liquid oral composition, and liquid oral composition | |
JP6264292B2 (en) | Dentifrice composition and tooth remineralization accelerator | |
KR20190076829A (en) | Oral composition and method for inhibiting discoloration thereof | |
JP2023005325A (en) | oral composition | |
JP2024092817A (en) | Liquid composition for oral cavity | |
JP2018104376A (en) | Dentifrice composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160324 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170523 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170724 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170829 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170911 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6217628 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |